Product Images Capecitabine 500mg

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Capecitabine 500mg NDC 72485-205 by Armas Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

72485205 2

72485205 2

This is a description of Capecitabine tablets, USP which is a cytotoxic agent. Each film-coated tablet contains 500 mg capecitabine, USP. It is recommended to swallow the tablets as a whole and not to crush or cut them. It is advised to read the accompanying insert for dosage recommendations and other important prescribing information. The tablets should be dispensed in tight containers as defined in USP guidelines and should be stored at a temperature of 25°C (77°F), with permitted excursions to 15° to 30°C (59° to 86°F). The tablets are manufactured by Shilpa Medicare Limited, India and distributed by Armas Pharmaceuticals, Inc, in Manalapan, NJ, USA.*

Figure 1 Kaplan-Meier Estimates of Disease-Free Survival (All Randomized Population)a - fig 1

Figure 1 Kaplan-Meier Estimates of Disease-Free Survival (All Randomized Population)a - fig 1

Figure 2 Kaplan-Meier Estimates of Overall Survival (All Randomized Population) - fig 2

Figure 2	Kaplan-Meier Estimates of Overall Survival (All Randomized Population) - fig 2

Figure 3 Kaplan-Meier Curve for Overall Survival of Pooled Data (Studies 1 and 2) - fig 3

Figure 3 Kaplan-Meier Curve for Overall Survival of Pooled Data (Studies 1 and 2) - fig 3

Figure 4 Kaplan-Meier Estimates for Time to Disease Progression Capecitabine and Docetaxel vs Docetaxel - fig 4

Figure 4 	Kaplan-Meier Estimates for Time to Disease Progression Capecitabine and Docetaxel vs Docetaxel - fig 4

Figure 5 Kaplan-Meier Estimates of Survival Capecitabine and Docetaxel vs Docetaxel - fig 5

Figure 5 Kaplan-Meier Estimates of Survival Capecitabine and Docetaxel vs Docetaxel - fig 5

This appears to be a chart or table showing estimated probabilities for different medication dosages and schedules. The medications listed are Docetaxel and Capecitabine, along with corresponding dosages in mg/sqm (milligrams per square meter) and frequency (e.g. every 3 weeks). Without additional context or information, it is not clear what the probabilities represent or how they were calculated.*

Metabolic Pathway - meta pathway

Metabolic Pathway - meta pathway

Structural Formula - structural formula

Structural Formula - structural formula

Not available.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.